To elucidate the mechanism by which EHF and CDX1 co-operate to drive CRC differentiation, we utilised the ATAC-seq data to interrogate how re-expression of these factors alters chromatin accessibility at the VIL1 promoter. Here, EHF is linked to colorectal carcinoma.